Taking the occasional loss comes part and parcel with investing on the stock market. And there's no doubt that Harvard Bioscience, Inc. (NASDAQ:HBIO) stock has had a really bad year. In that ...

The Computer and Technology group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Harvard Bioscience (HBIO) is a stock that can ...

As investors, we look for growing companies that can produce returns. Having said that, Harvard Bioscience stock looks ready for a run following yet another earnings beat. Will HBIO stock continue to ...

An announcement from Harvard Bioscience ( (HBIO)) is now available. Harvard Bioscience has outlined a strategic transformation toward translational science tools in an investor presentation dated May ...

Harvard Bioscience, Inc. (NASDAQ:HBIO) was in 8 hedge funds’ portfolio at the end of March. HBIO shareholders have witnessed an increase in activity from the world’s largest hedge funds in recent ...

Harvard Bioscience ( (HBIO)) just unveiled an update. On January 19, 2026, Harvard Bioscience’s Board of Directors approved an amendment to the company’s Amended and Restated By-laws that lowers the ...

Short interest in Harvard Bioscience Inc (NASDAQ:HBIO) increased during the last reporting period, rising from 350.56K to 398.85K. This put 0.98% of the company's publicly available shares short.